CDKN2A and neoplasm: Notably, we also detected p16 promoter methylation in a tumor-free, but premalignant lesion-containing mammary tissue in the mouse 1497 (Figure 4C), which explains why there was not a significant decrease in p16 expression between tumor vs tumor-free tissues in mouse 1497 (Figure 4A).